Michigan Expanding Access to Safe, Effective COVID-19 Vaccine

COVID Vaccine | MI Safe Start | Mask Up, Michigan
Test Site Finder | MI COVID Alert

COVID-19 Vaccine Data

We have distributed 3,410,285 vaccines to state partners and federal programs for administration. We have reported administering 2,753,502 doses of vaccines for priority groups (as of March 9). This data is current data as of March 10, 2021 unless otherwise noted.

Prioritization Guidance Updates

The state is expanding vaccination eligibility for Michiganders ages 16 and older with disabilities or medical conditions that put them at high risk of negative COVID-19 outcome beginning Monday, March 22. The state has also announced that beginning Monday, April 5, all Michiganders age 16 and up who were not previously eligible will be eligible to receive a vaccine. View the most recent prioritization guidelines.

Michigan Named One of the Few States in the Nation to Receive a Regional Community Vaccination Site 

Governor Gretchen Whitmer announced that an eight-week mass vaccination site with the capacity to administer 6,000 doses each day will open on March 24 at Ford Field in Detroit to serve residents in the broader southeast Michigan region. 

The Biden Administration in partnership with the Federal Emergency Management Agency (FEMA) selected southeast Michigan for this major new community vaccination site. The site, which was selected according to the CDC’s priority tool to help those hardest hit and most vulnerable, will operate from 8 a.m. to 8:30 p.m., seven days a week, for eight weeks under the federal government's vaccination pilot program. 

The facility will be managed by the State of Michigan with support from FEMA, Wayne County, the City of Detroit, Ford Field, Meijer, Henry Ford Health System, and the Lions. 

All Three Vaccines are Safe and Effective

Vaccination is an important tool in stopping the spread of COVID-19. As a provider, your opinion on vaccination matters. Encourage patients to get the vaccine available to them, and not wait for a specific brand.

All three vaccines in circulation demonstrate high efficacy against COVID-19, particularly with preventing hospitalizations, severe illness, and deaths. The vaccines have comparable safety profiles, with the Janssen COVID-19 (Johnson & Johnson) vaccine having the benefit of a single dose.

B.1.351 Variant Identified In Michigan

The first Michigan case of the COVID-19 variant B.1.351 was identified in a male child living in Jackson County by the Michigan Department of Health and Human Services (MDHHS) Bureau of Laboratories. Originally detected in early October 2020 in South Africa, B.1.351 shares some mutations with B.1.1.7.

Impact on Vaccination

• B1.1.7: There is little indication that B.1.1.7 exhibits any changes in the virus that would impact the effectiveness of current vaccines. B.1.1.7 has been identified in Michigan.
• B1.351: Less is known about the B.1.351 variant at this time. The Janssen COVID-19 vaccine was tested in South Africa where the B.1.351 variant was spreading rampantly and the vaccine offered some protection against the virus. Additional studies are needed to fully understand potential impacts of the variant strain on vaccine efficacy. The first case of B.1.351 in Michigan was identified March 8, 2021.
• P.1: There is evidence to suggest that some of the mutations in the P.1 variant may affect the ability of antibodies (from natural infection or vaccination) to recognize and neutralize the virus, but additional studies are needed. P.1 has not been identified in Michigan.

Variants of concern are being closely investigated and additional studies are ongoing. Continuation of public health strategies such as vaccination, physical distancing, use of masks, hand hygiene, and isolation and quarantine are essential to limit the spread of the virus that causes COVID-19 and protect the public.

Visit the CDCs New COVID-19 Variants web page for additional information.

For the most current information, please visit Michigan.gov/Coronavirus.